CoChat

Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens

Open access
Malekzadeh, Parisa, Yossef, Rami, Cafri, Gal, Paria, Biman C., Lowery, Frank J., Jafferji, Mohammad, Good, Meghan L., Sachs, Abraham, Copeland, Amy R., Kim, Sanghyun P., Kivitz, Scott, Parkhurst, Maria R., Robbins, Paul F., Ray, Satyajit, Xi, Liqiang, Raffeld, Mark, Yu, Zhiya, Restifo, Nicholas P., Somerville, Robert P.T., Rosenberg, Steven A., Deniger, Drew C. · 2020 · Clinical Cancer Research
Cited by 118

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Purpose: The purpose of this study was to evaluate antigen experienced T cells in peripheral blood lymphocytes (PBL) for responses to p53 neoantigens. Experimental Design: PBLs from patients with a mutated TP53 tumor were sorted for antigen-experienced T cells and in vitro stimulation (IVS) was performed with p53 neoantigens. The IVS cultures were stimulated with antigen-presenting cells expressing p53 neoantigens, enriched for 41BB/OX40 and grown with rapid expansion protocol. Results: T-cell responses were not observed in the PBLs of 4 patients who did not have tumor-infiltrating lymphocyte (TIL) responses to mutated TP53. In contrast, 5 patients with TIL responses to mutated TP53 also had similar T-cell responses in their PBLs, indicating that the PBLs and TILs were congruent in p53 neoantigen reactivity. CD4+ and CD8+ T cells were specific for p53R175H, p53Y220C, or p53R248W neoantigens, including a 78% reactive T-cell culture against p53R175H and HLA-A*02:01. Tracking TCRB clonotypes (clonality, top ranked, and TP53 mutation-specific) supported the enrichment of p53 neoantigen–reactive T cells from PBLs. The same T-cell receptor (TCR) from the TIL was found in the IVS cultures in three cases and multiple unique TCRs were found in another patient. TP53 mutation–specific T cells also recognized tumor cell lines bearing the appropriate human leukocyte antigen restriction element and TP53 mutation, indicating these T cells could recognize processed and presented p53 neoantigens. Conclusions: PBL was a noninvasive source of T cells targeting TP53 mutations for cell therapy and can provide a window into intratumoral p53 neoantigen immune responses. See related commentary by Olivera et al., p. 1203

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-19-1874

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 118

Metadata

Authors
Malekzadeh, P., Yossef, R., Cafri, G., Paria, B. C., Lowery, F. J., Jafferji, M., Good, M. L., Sachs, A., Copeland, A. R., Kim, S. P., Kivitz, S., Parkhurst, M. R., Robbins, P. F., Ray, S., Xi, L., Raffeld, M., Yu, Z., Restifo, N. P., Somerville, R. P. T., Rosenberg, S. A., & Deniger, D. C.
Venue
Clinical Cancer Research
Published
2020-03-13
Volume
26
Issue
6
Pages
1267-1276
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W3004398085
Cited by
118
References
4
FWCI
5.78
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-19-1874
The paper
Malekzadeh, P., Yossef, R., Cafri, G., Paria, B. C., Lowery, F. J., Jafferji, M., Good, M. L., Sachs, A., Copeland, A. R., Kim, S. P., Kivitz, S., Parkhurst, M. R., Robbins, P. F., Ray, S., Xi, L., Raffeld, M., Yu, Z., Restifo, N. P., Somerville, R. P. T., . . . Deniger, D. C. (2020). Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-19-1874

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.